18F-FLT实验研究与临床应用进展

The experimental study and clinical application progress of 18F-fluorothymidine

  • 摘要: 放射性核素标记的胸腺嘧啶类似物能够在一定程度上反映细胞增殖的状况,3'-脱氧-3'-18F-氟代胸苷(3'-deoxy-3'-18F-fluorothymidine,18F-FLT)是此类药物中发展较为完善的一种示踪剂。18F-FLT PET通过反映胸苷激酶-1的活性而间接反映肿瘤细胞的增殖状况,有助于对肿瘤进行良恶性鉴别、疗效评估和预后判断,是一种具有良好应用前景的PET显像剂。

     

    Abstract: 3'-deoxy-3'-18F-fluorothymidine (18F-FLT)is a promising tracer derived from thymidine. Accumulation of 18F-FLT is dependent on cellular thymidine kinase-1 (TK-1)activity. This enzyme is functional only in cells undergoing DNA replication during the S phase of the cell cycle.18F-fluorothymidine PET thus be able to image of cell proliferation in vivo for diagnosis, staging and monitoring of treatment re-sponse. Its advancements in basic and clinical studies will be reviewed in this article.

     

/

返回文章
返回